Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan

Taiwan has strictly followed infection control measures to prevent spread of coronavirus disease. Meanwhile, nationwide surveillance data revealed drastic decreases in influenza diagnoses in outpatient departments, positivity rates of clinical specimens, and confirmed severe cases during the first 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Shu-Chen, Shih, Shu-Man, Chien, Li-Hsin, Hsiung, Chao A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392415/
https://www.ncbi.nlm.nih.gov/pubmed/32339091
http://dx.doi.org/10.3201/eid2608.201192
_version_ 1783564842442948608
author Kuo, Shu-Chen
Shih, Shu-Man
Chien, Li-Hsin
Hsiung, Chao A.
author_facet Kuo, Shu-Chen
Shih, Shu-Man
Chien, Li-Hsin
Hsiung, Chao A.
author_sort Kuo, Shu-Chen
collection PubMed
description Taiwan has strictly followed infection control measures to prevent spread of coronavirus disease. Meanwhile, nationwide surveillance data revealed drastic decreases in influenza diagnoses in outpatient departments, positivity rates of clinical specimens, and confirmed severe cases during the first 12 weeks of 2020 compared with the same period of 2019.
format Online
Article
Text
id pubmed-7392415
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-73924152020-08-06 Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan Kuo, Shu-Chen Shih, Shu-Man Chien, Li-Hsin Hsiung, Chao A. Emerg Infect Dis Research Letter Taiwan has strictly followed infection control measures to prevent spread of coronavirus disease. Meanwhile, nationwide surveillance data revealed drastic decreases in influenza diagnoses in outpatient departments, positivity rates of clinical specimens, and confirmed severe cases during the first 12 weeks of 2020 compared with the same period of 2019. Centers for Disease Control and Prevention 2020-08 /pmc/articles/PMC7392415/ /pubmed/32339091 http://dx.doi.org/10.3201/eid2608.201192 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
Kuo, Shu-Chen
Shih, Shu-Man
Chien, Li-Hsin
Hsiung, Chao A.
Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan
title Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan
title_full Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan
title_fullStr Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan
title_full_unstemmed Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan
title_short Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan
title_sort collateral benefit of covid-19 control measures on influenza activity, taiwan
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392415/
https://www.ncbi.nlm.nih.gov/pubmed/32339091
http://dx.doi.org/10.3201/eid2608.201192
work_keys_str_mv AT kuoshuchen collateralbenefitofcovid19controlmeasuresoninfluenzaactivitytaiwan
AT shihshuman collateralbenefitofcovid19controlmeasuresoninfluenzaactivitytaiwan
AT chienlihsin collateralbenefitofcovid19controlmeasuresoninfluenzaactivitytaiwan
AT hsiungchaoa collateralbenefitofcovid19controlmeasuresoninfluenzaactivitytaiwan

Ejemplares similares